Attached files

file filename
10-K - 10-K - STERIS plcste-20210331.htm
EX-32.1 - EX-32.1 - STERIS plcste03312021ex321.htm
EX-31.2 - EX-31.2 - STERIS plcste03312021ex312.htm
EX-31.1 - EX-31.1 - STERIS plcste03312021ex311.htm
EX-24.1 - EX-24.1 - STERIS plcste03312021ex241.htm
EX-22.1 - EX-22.1 - STERIS plcste03312021ex221.htm
EX-21.1 - EX-21.1 - STERIS plcste03312021ex211.htm
EX-18.1 - EX-18.1 - STERIS plcexhibit181.htm
EX-4.5 - EX-4.5 - STERIS plca03312021ex45.htm

Exhibit 23.1



Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)    Registration Statement (Form S-8, No. 333-230557) of STERIS plc pertaining to the STERIS Corporation 401(k) Plan,
(2)    Registration Statement (Form S-8, No. 333-230558) of STERIS plc pertaining to the STERIS plc 2006 Long-Term Equity Incentive Plan (As Assumed, Amended and Restated Effective March 28, 2019), and
(3)    Registration Statement (Form S-3, No. 333-254608) of STERIS plc, STERIS Corporation, STERIS Ltd, and STERIS Irish FinCo Unlimited Co pertaining to the registration of debt securities, guarantees of debt securities, ordinary shares, preferred shares, warrants, and units;

of our reports dated May 28, 2021, with respect to the consolidated financial statements and schedule of STERIS plc and subsidiaries (STERIS) and the effectiveness of internal control over financial reporting of STERIS included in this Annual Report (Form 10-K) of STERIS for the year ended March 31, 2021.
    


 
/s/ Ernst & Young LLP

Cleveland, Ohio
May 28, 2021